Mangalam Drugs & Organics Dirección
Dirección controles de criterios 3/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Govardhan Dhoot
Chief Executive Officer (CEO)
₹2.0m
Compensación total
| Porcentaje del salario del CEO | 100.0% |
| Permanencia del CEO | 28.3yrs |
| Participación del CEO | 6.8% |
| Permanencia media de la dirección | sin datos |
| Promedio de permanencia en la Junta Directiva | 6.5yrs |
Actualizaciones recientes de la dirección
Recent updates
Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Revenues Are Not Doing Enough For Some Investors
Aug 13
A Look At The Intrinsic Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
May 23Little Excitement Around Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Revenues As Shares Take 25% Pounding
Mar 28Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Shares Lagging The Industry But So Is The Business
Feb 07Estimating The Fair Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
Oct 20Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?
Mar 29These 4 Measures Indicate That Mangalam Drugs & Organics (NSE:MANGALAM) Is Using Debt Extensively
May 31A Look At The Fair Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
Apr 06We Think Mangalam Drugs & Organics (NSE:MANGALAM) Is Taking Some Risk With Its Debt
Jan 03Here's Why Mangalam Drugs & Organics (NSE:MANGALAM) Can Manage Its Debt Responsibly
May 23Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?
Jan 04Do Its Financials Have Any Role To Play In Driving Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Stock Up Recently?
Nov 12
A Look At The Intrinsic Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
Sep 20Does Mangalam Drugs & Organics's (NSE:MANGALAM) Statutory Profit Adequately Reflect Its Underlying Profit?
Aug 05We Think Mangalam Drugs & Organics (NSE:MANGALAM) Can Stay On Top Of Its Debt
Jul 01Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -₹91m |
| Dec 31 2023 | n/a | n/a | -₹170m |
| Sep 30 2023 | n/a | n/a | -₹171m |
| Jun 30 2023 | n/a | n/a | -₹113m |
| Mar 31 2023 | ₹2m | ₹2m | ₹13m |
| Dec 31 2022 | n/a | n/a | ₹123m |
| Sep 30 2022 | n/a | n/a | ₹159m |
| Jun 30 2022 | n/a | n/a | ₹182m |
| Mar 31 2022 | ₹2m | ₹2m | ₹197m |
| Dec 31 2021 | n/a | n/a | ₹151m |
| Sep 30 2021 | n/a | n/a | ₹175m |
| Jun 30 2021 | n/a | n/a | ₹241m |
| Mar 31 2021 | ₹2m | n/a | ₹280m |
| Dec 31 2020 | n/a | n/a | ₹309m |
| Sep 30 2020 | n/a | n/a | ₹261m |
| Jun 30 2020 | n/a | n/a | ₹158m |
| Mar 31 2020 | ₹5m | ₹2m | ₹83m |
| Dec 31 2019 | n/a | n/a | -₹28m |
| Sep 30 2019 | n/a | n/a | -₹89m |
| Jun 30 2019 | n/a | n/a | -₹80m |
| Mar 31 2019 | ₹2m | ₹2m | -₹80m |
| Dec 31 2018 | n/a | n/a | ₹10m |
| Sep 30 2018 | n/a | n/a | ₹114m |
| Jun 30 2018 | n/a | n/a | ₹164m |
| Mar 31 2018 | ₹2m | ₹2m | ₹199m |
Compensación vs. Mercado: La compensación total de Govardhan($USD23.97K) está por debajo de la media de empresas de tamaño similar en el mercado Indian ($USD38.53K).
Compensación vs. Ingresos: La compensación de Govardhan ha sido consistente con los resultados de la empresa en el último año.
CEO
Govardhan Dhoot (71 yo)
28.3yrs
Permanencia
₹2,000,000
Compensación
Mr. Govardhan Murlidhar Dhoot serves as the Chairman of the Board and Managing Director at Mangalam Drugs & Organics Limited and has been its Executive Director since April 16, 1996.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman & MD | 28.3yrs | ₹2.00m | 6.81% ₹ 134.6m | |
| Whole-Time Director | 9.3yrs | ₹600.00k | 3.57% ₹ 70.6m | |
| Independent Director | 6.8yrs | ₹36.00k | sin datos | |
| Non-Executive Independent Director | 6.3yrs | ₹42.00k | sin datos | |
| Independent Non-Executive Director | 3.4yrs | ₹24.00k | sin datos | |
| Non-Executive Non- Independent Director | 2.4yrs | ₹16.00k | sin datos |
6.5yrs
Permanencia media
69yo
Promedio de edad
Junta con experiencia: La junta directiva de MANGALAM se considera experimentada (6.2 años de antigüedad promedio).